Business
UPDATE – Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses
HONG KONG, March 09, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ: GV) (“the Company”), a technology-driven multinational enterprise focused on biotechnology and healthcare, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited (“GV Hong Kong”), has signed a US$12 million exclusive distribution agreement for its flagship anti-aging product, Premier Regenerative Complex-President Super Injection, in cooperation with Huajin China Investment Company
About this update from Visionary Holdings Inc.
[{"type":"text","content":"HONG KONG, March 09, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ: GV) (“the Company”), a technology-driven multinational enterprise focused on biotechnology and healthcare, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited (“GV Hong Kong”), has signed a US$12 million exclusive distribution agreement for its flagship anti-aging product, Premier Regenerative Complex-President Super Injection, in cooperation with Huajin China Investment Company（”Huajin China”), alongside the Board-approved divestiture of its non-core business.","length":584,"tagName":"p"},{"type":"text","content":"These strategic actions mark the Company’s formal transition into a commercialization acceleration phase within the high-end medical aesthetics sector.","length":151,"tagName":"p"},{"type":"text","content":"Commercialization Milestone for Premier Regenerative Complex – President Super InjectionThe Company’s wholly owned subsidiary, Visionary Health Technology Group Limited, has entered into an exclusive distribution agreement with Huajin China, establishing a minimum contracted sales target of US$12 million within a 12-month period. Revenue recognition will be subject to product delivery, customer acceptance, and applicable accounting standards.","length":447,"tagName":"p"},{"type":"text","content":"This agreement represents a significant step in scaling the commercial deployment of Premier Regenerative Complex – President Super Injection, reflecting growing market acceptance and strengthening revenue visibility.","length":217,"tagName":"p"},{"type":"text","content":"Strategic Divestiture to Concentrate on Core Medical Aesthetics TrackOn February 27, 2026, the Company’s Board of Directors approved the transfer of 100% equity interests in Visionary Education Services & Management Inc. to Cai Dao Trading Ltd., completing the planned exit from non-core legacy business operations. In addition, in light of the Company’s evolving business development needs, the Board also approved a change in the Company’s transfer agent service provider.","length":479,"tagName":"p"},{"type":"text","content":"Following this divestiture, Visionary Holdings will operate as a streamlined biotechnology and healthcare-focused enterprise, allocating capital, technology and management resources exclusively toward:","length":20...